ACTN1 and squamous cell carcinoma: Next, we evaluated the in vitro activity and off-target mitigation potential of ACTN1 siRNAs modified with iBu and MOP at positions 6-7 (Table 1, line 6) in the A431 epidermoid carcinoma cell line.